118973-06-1

Upstream product

• 118973-17-4 [4-(6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)benzyl]-tetrahydropyran-2-yl ether 

Downstream Products

• 118973-07-2 4-(6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)benzyl acetoacetate 
• 119199-57-4 4-(6-Oxo-1,4,5,6-tetrahydropyridazin-3-yl)benzyl 4-(3-chlorophenyl)-1,4-dihydro-2,6-dimethyl-5-nitropyridine-3-carboxylate 
• 118973-23-2 Ethyl 4-(6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)benzyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-pyridine-3,5-dicarboxylate 

Relevant academic research and scientific papers

Circulation-active dihydropyridine ethers

Cardioactive novel dihydropyridine ethers of the formula STR1 in which R1 -stands for cyano, nitro or for a -COOR5 group, wherein R5 -denotes straight-chain, branched or cyclic alkyl having up to 6 carbon atoms, which can

Substituted 1,4-dihydropyridines for control of circulation and thromboses

For the control of coronary diseases and thromboses there are provided the novel compounds STR1 in which R1 is an optionally substituted phenyl or heterocyclic radical, R2 is a cyano, keto, carboxy, ester or amide group, and X is fro